Daniel Brims

Stock Analyst at Lake Street

(1.86)
# 3,278
Out of 5,237 analysts
1
Total ratings
100%
Success rate
3.96%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Daniel Brims

Kura Oncology
Apr 14, 2026
Initiates: Buy
Price Target: $23
Current: $9.61
Upside: +139.33%